Investing.com - Novavax reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Novavax announced earnings per share of $-2.15 on revenue of $735M. Analysts polled by Investing.com anticipated EPS of $1.63 on revenue of $623.9M.
Novavax shares are down 35% from the beginning of the year , still down 91.69% from its 52 week high of $236.50 set on Monday, December 20, 2021.
Novavax shares gained 1.78% in after-hours trade the report.
Novavax follows other major Healthcare sector earnings this month
Novavax's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar